Pnc Financial Services Group, Inc. Novo Nordisk A S Transaction History

Pnc Financial Services Group, Inc.

$156 Billion
Q3 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 561,538 shares of NVO stock, worth $60.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

561,538

Previous 565,459 0.69%

Holding current value

$60.7 Million

Previous $80.7 Million 17.16%

% of portfolio

0.04%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$119.07 - $145.42 $466,873 - $570,191	-3,921 Reduced 0.69%	561,538 $66.9 Million
Q2 2024 Aug 09, 2024	SELL	$122.71 - $146.91 $1.23 Million - $1.47 Million	-10,021 Reduced 1.74%	565,459 $80.7 Million
Q1 2024 May 10, 2024	SELL	$102.11 - $135.92 $7.37 Million - $9.8 Million	-72,134 Reduced 11.14%	575,480 $73.9 Million
Q4 2023 Feb 09, 2024	BUY	$87.78 - $105.45 $1.99 Million - $2.39 Million	22,669 Added 3.63%	647,614 $67 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $28.6 Million - $62.8 Million	314,624 Added 101.39%	624,945 $56.8 Million
Q2 2023 Aug 11, 2023	SELL	$155.98 - $172.65 $86,256 - $95,475	-553 Reduced 0.18%	310,321 $50.2 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $423,752 - $509,566	-3,202 Reduced 1.02%	310,874 $49.5 Million
Q4 2022 Feb 10, 2023	SELL	$102.55 - $135.33 $548,334 - $723,609	-5,347 Reduced 1.67%	314,076 $42.5 Million
Q3 2022 Nov 10, 2022	BUY	$95.28 - $116.93 $72,889 - $89,451	765 Added 0.24%	319,423 $31.8 Million
Q2 2022 Aug 12, 2022	BUY	$103.24 - $121.81 $334,910 - $395,151	3,244 Added 1.03%	318,658 $35.5 Million
Q1 2022 May 12, 2022	BUY	$93.1 - $112.54 $357,410 - $432,041	3,839 Added 1.23%	315,414 $35 Million
Q4 2021 Feb 11, 2022	BUY	$95.88 - $117.08 $4.48 Million - $5.47 Million	46,685 Added 17.62%	311,575 $34.9 Million
Q3 2021 Nov 05, 2021	SELL	$84.42 - $106.62 $364,441 - $460,278	-4,317 Reduced 1.6%	264,890 $25.4 Million
Q2 2021 Aug 06, 2021	BUY	$67.66 - $84.76 $155,009 - $194,185	2,291 Added 0.86%	269,207 $22.6 Million
Q1 2021 May 07, 2021	SELL	$67.06 - $75.82 $10.6 Million - $12 Million	-157,942 Reduced 37.18%	266,916 $18 Million
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $2.12 Million - $2.45 Million	-33,145 Reduced 7.24%	424,858 $29.7 Million
Q3 2020 Nov 06, 2020	BUY	$63.69 - $70.22 $43,818 - $48,311	688 Added 0.15%	458,003 $31.8 Million
Q2 2020 Aug 07, 2020	SELL	$58.54 - $67.94 $155,365 - $180,312	-2,654 Reduced 0.58%	457,315 $29.9 Million
Q1 2020 May 08, 2020	SELL	$49.46 - $64.78 $36,402 - $47,678	-736 Reduced 0.16%	459,969 $27.7 Million
Q4 2019 Feb 07, 2020	SELL	$49.86 - $58.26 $526,870 - $615,633	-10,567 Reduced 2.24%	460,705 $26.7 Million
Q3 2019 Nov 08, 2019	SELL	$47.54 - $53.43 $357,025 - $401,259	-7,510 Reduced 1.57%	471,272 $24.4 Million
Q2 2019 Aug 09, 2019	BUY	$46.79 - $52.47 $2,854 - $3,200	61 Added 0.01%	478,782 $0
Q1 2019 May 10, 2019	SELL	$46.36 - $52.63 $222,713 - $252,834	-4,804 Reduced 0.99%	478,721 $0
Q4 2018 Feb 08, 2019	SELL	$41.54 - $47.25 $8.96 Million - $10.2 Million	-215,617 Reduced 30.84%	483,525 $22.3 Million
Q3 2018 Nov 09, 2018	BUY	$46.76 - $51.24 $9.61 Million - $10.5 Million	205,480 Added 41.62%	699,142 $0
Q2 2018 Aug 10, 2018	SELL	$44.29 - $50.42 $9,832 - $11,193	-222 Reduced 0.04%	493,662 $0
Q1 2018 May 11, 2018	SELL	$48.49 - $58.14 $387 - $465	-8 Reduced -0.0%	493,884 $0
Q4 2017 Feb 09, 2018	SELL	$47.53 - $53.73 $36,788 - $41,587	-774 Reduced 0.16%	493,892 $0
Q3 2017 Nov 13, 2017	BUY	$41.15 - $49.22 $20.4 Million - $24.3 Million	494,666	494,666 $0

Others Institutions Holding NVO

# of Institutions

1,956

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $244B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Novo Nordisk A S Transaction History